ACS - Acute Coronary Syndrome
Conditions
Keywords
Telemedicine follow-up visit, Post-ACS rehabilitation
Brief summary
The aim is to compare the safety of using telemedicine and office visit follow-up in post-acute coronary syndrome patients
Detailed description
Rehabilitation after acute coronary syndrome includes visits to the cardiologist's office at 1, 2, 6 and 12 months after discharge. Due to the Covid-19 pandemic, visiting a cardiologist's office maybe impossible. In such cases telemedicine follow-up visit would be reasonable choice. Taking into account the absence of studies in this area, providing investigation evaluating parameters of safety for both methodics is relevant.
Interventions
OTHERTelemedicine FU
Participant will get telemedicine follow-up visit at 1, 3, and 6 months or 1 and 6 months after discharge from hospital.
OTHEROffice FU
Participant will get office follow-up visit at 1, 3, and 6 months or 1 and 6 months after discharge from hospital.
Sponsors
Tomsk National Research Medical Center of the Russian Academy of Sciences
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Signed informed consent 2. Age ≥ 40 years 3. PCI with coronary artery stenting for ACS 4. Angiographic success PCI
Exclusion criteria
1. Patients with cancer 2. Severe CHF (EF LV \<35% or functional class of heart failure III-IV NYHA) 3. Severe valvular heart disease or Prosthetic heart valves. 4. Severe forms of CKD (GFR\<30mL/min) 5. Planned staged revascularization during the next 12 months 6. Planned surgery within the next 12 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| MACCE | 1 year | Major adverse cardiac and cerebrovascular events: cardiac death, myocardial infarction, or stroke |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| High level of MT optimization | 1 year | High Level of Medical Therapy Optimization is defined as a participant meeting all of the following goals: LDL \< 1.4 mmol/L and on any statin, blood pressure \< 140/90 mm/Hg (\<135/85 mm/Hg for patients with diabetes mellitus), on aspirin or other antiplatelet or anticoagulant, and not smoking. High level of medical therapy optimization is missing if any of the individual goals are missing. |
| PB < 140/90 mm/Hg (<135/85 mm/Hg for Diabetes) | 1 year | Blood pressure \< 140 mm/Hg (\<135/85 mm/Hg for for patients with diabetes mellitus) |
| LDL < 1.4 mmol/L | 1 year | Low density lipoprotein\< 1.4 mmol/L |
| Not smoking | 1 year | Not smoking |
| Decrease in overweight | 1 year | Decrease in overweight |
| Aspirin or other antiplatelet or anticoagulant | 1 year | Adherence to aspirin or other antiplatelet or anticoagulant |
| Adherence to prescribed medication | 1 year | Adherence to prescribed at discharge medication |
| Hospitalization | 1 year | Hospitalization for cardiac reasons |
Countries
Russia
Contacts
PRINCIPAL_INVESTIGATORIvan S Bessonov, MD, PhD
Tyumen Cardiology Research Center
Outcome results
None listed